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Elaine A. Lidington, PhD, Justin C. Mason, FRCP, PhD, Dorian O. Haskard, DM, PhD,
Anna M. Randi, MD, PhD, and R. Clive Landis, PhD, London, United Kingdom, and
Bridgetown, Barbados
Thrombin generation remains a problem during operations requiring cardiopulmonary bypass.
This study demonstrates that activation of the thrombin receptor protease-activated receptor 1
on endothelial cells and the resulting proinflammatory response is blocked by aprotinin. These
findings provide a new likely mechanism for the well-established anti-inflammatory properties
of aprotinin.
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28 Clinical outcomes of nonelective coronary revascularization with and
without cardiopulmonary bypass
Sotiris C. Stamou, MD, PhD, Peter C. Hill, MD, Elizabeth Haile, MS, Syma Prince, RN,
Michael J. Mack, MD, and Paul J. Corso, MD, Cleveland, Ohio, Washington, DC, and Dallas, Tex
Non-elective coronary artery bypass without cardiopulmonary bypass is associated with
comparable operative mortality and stroke and abbreviated length of stay compared to
conventional on-pump approach. Off-pump CABG may also decrease the need for intraaortic
balloon pump placement and lower the rate of postoperative renal failure and hemorrhage-
related reexploration compared to conventional on-pump CABG.
34 Improved myocardial protection during coronary artery surgery with
glucose-insulin-potassium: A randomized controlled trial ■
David W. Quinn, BSc, FRCS, Domenico Pagano, MD, FRCS, FESC,
Robert S. Bonser, FRCP, FRCS, FESC, Stephen J. Rooney, MB, FRCS,
Timothy R. Graham, MB, FRCS, Ian C. Wilson, MD, FRCS, Bruce E. Keogh, MD, FRCS,
John N. Townend, MD, FRCP, Michael E. Lewis, MD, FRCS, Peter Nightingale, PhD, and the
Study Investigators, Birmingham, United Kingdom
Systemic glucose-insulin-potassium administered during coronary artery bypass grafting
improves myocardial protection and cardiac index and reduces inotrope requirements and the
incidence of low cardiac output episodes.
General Thoracic
Surgery
(GTS)
43 Predictors of operative mortality and cardiopulmonary morbidity in the
National Emphysema Treatment Trial
Keith S. Naunheim, MD, Douglas E. Wood, MD, Mark J. Krasna, MD,
Malcolm M. DeCamp, Jr, MD, Mark E. Ginsburg, MD, Robert J. McKenna, Jr, MD,
Gerard J. Criner, MD, Eric A. Hoffman, PhD, Alice L. Sternberg, ScM, and
Claude Deschamps, MD, for the National Emphysema Treatment Trial Research Group, St
Louis, Mo, Seattle, Wash, Baltimore, Md, Cleveland, Ohio, New Hyde Park, NY, Los Angeles,
Calif, Philadelphia, Pa, Iowa City, Iowa, and Rochester, Minn
The purpose of this article is to identify preoperative predictors of mortality and
cardiopulmonary morbidity in patients undergoing lung volume reduction surgery as part of the
National Emphysema Treatment Trial. Only non–upper-lobe-predominant emphysema was
predictive of operative mortality.
54 Robotic assistance for video-assisted thoracic surgical lobectomy: Technique
and initial results
Bernard J. Park, MD, Raja M. Flores, MD, and Valerie W. Rusch, MD, New York, NY
Telerobotic assistance for VATS surgical lobectomy has been developed with 3 standard
thoracoscopic ports. The use of robotic instruments is feasible and safe.
60 Prolongation of patency of airway bypass stents with use of drug-eluting stents
Cliff K. Choong, FRACS, Loc Phan, BSC, Patrick Massetti, BSC, Fabio J. Haddad, MD,
Carlo Martinez, MD, Edmund Roschak, BSC, and Joel D. Cooper, MD, St Louis, Mo, and
Mountain View, Calif
In a canine model, the use of a specifically designed paclitaxel-eluting airway bypass stent was
found to be feasible and safe. It resulted in a significant prolongation of stent patency.
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65 Endoscopic ultrasonography-identified celiac adenopathy remains a poor
prognostic factor despite preoperative chemoradiotherapy in esophageal
adenocarcinoma
S. Chris Malaisrie, MD, Wayne L. Hofstetter, MD, Arlene M. Correa, PhD,
Jaffer A. Ajani, MD, Ritsuko R. Komaki, MD, Zhongxing Liao, MD, Alexandria Phan,
David C. Rice, MD, Ara A. Vaporciyan, MD, Garrett L. Walsh, MD, Sandeep Lahoti, MD,
Jeffrey H. Lee, MD, Robert Bresalier, MD, Jack A. Roth, MD, and Stephen G. Swisher, MD,
Houston, Tex
Celiac adenopathy has been associated with poor survival in patients with esophageal cancer treated
with surgical intervention alone. This study demonstrates that endoscopic ultrasonography–identified
celiac adenopathy in patients with adenocarcinoma of the distal esophagus remains a poor
prognostic factor despite preoperative chemoradiotherapy. Future multimodality trials should stratify
these patients. The evaluation of novel strategies, including induction chemotherapy before
concurrent chemoradiotherapy, might be warranted in this high-risk group of patients.
73 Risk factors for primary graft dysfunction after lung transplantation
Bryan A. Whitson, MD, Dilip S. Nath, MD, Adam C. Johnson, MD, Adam R. Walker, BS,
Matthew E. Prekker, MD, David M. Radosevich, PhD, Cynthia S. Herrington, MD, and
Peter S. Dahlberg, MD, PhD, Minneapolis, Minn
Increasing preoperative pulmonary artery pressures and donor age are associated with the
development of severe primary graft dysfunction after lung transplantation.
81 Long-term results after carinal resection for carcinoma: Does the benefit
warrant the risk?
Marc de Perrot, MD, Elie Fadel, MD, Olaf Mercier, MD, Sacha Mussot, MD,
Alain Chapelier, MD, and Philippe Dartevelle, MD, Le Plessis-Robinson, France
Carinal resection for carcinoma is feasible, with acceptable mortality and good long-term
survival in selected patients.
Surgery for Acquired
Cardiovascular Disease
(ACD)
90 Influence of patient characteristics and arterial grafts on freedom from
coronary reoperation
Joseph F. Sabik III, MD, Eugene H. Blackstone, MD, A. Marc Gillinov, MD,
Michael K. Banbury, MD, Nicholas G. Smedira, MD, and Bruce W. Lytle, MD, Cleveland, Ohio
Patient characteristics and operative techniques were evaluated to determine factors that predict
the need for or bias toward coronary reoperation. Arteriosclerosis risk factors increased the
likelihood of reoperation, and patient comorbidity and arterial grafting decreased it. Aggressive
risk-factor reduction and arterial revascularization should result in fewer coronary reoperations.
99 Seven years’ experience with suture annuloplasty for mitral valve repair Œ
Tayfun Aybek, MD, Petar Risteski, MD, Aleksandra Miskovic, MD, Andreas Simon, MD,
Selami Dogan, MD, Ulf Abdel-Rahman, MD, and Anton Moritz, MD, PhD, Frankfurt/Main, Germany
We aimed to assess the durability, hemodynamic performance, and clinical outcome of a suture
annuloplasty procedure for mitral valve repair. Follow-up showed satisfactory hemodynamic
performance and clinical outcome. Progressive annular dilatation during follow-up raised
concerns about the durability of the procedure.
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107 Should the “elephant trunk” be skeletonized? Total arch replacement
combined with stented elephant trunk implantation for Stanford type A
aortic dissection
Zhi-Gang Liu, MD, Li-Zhong Sun, MD, Qian Chang, MD, Jun-Ming Zhu, MD,
Chao Dong, MD, Chun-Tao Yu, MD, Yong-Min Liu, MD, and Hai-Tao Zhang, MD, Beijing,
China
Sixty consecutive patients with acute (n  36) or chronic (n  24) type A aortic dissection
underwent total aortic arch replacement combined with stented graft implantation into the
descending aorta: the skeletonized “elephant trunk” procedure. Fifty-eight patients survived and
were discharged. There were 2 in-hospital deaths (mortality, 3.3%). Herein we report the
outcomes of our experience and the problems we encountered.
114 Single crossclamp improves 6-month cognitive outcome in high-risk
coronary bypass patients: The effect of reduced aortic manipulation
John W. Hammon, MD, David A. Stump, PhD, John F. Butterworth, MD,
Dixon M. Moody, MD, Kashemi Rorie, PhD, Dwight D. Deal, BS, Edward H. Kincaid, MD,
Timothy E. Oaks, MD, and Neal D. Kon, MD, Winston-Salem, NC
A trial comparing single aortic clamping, multiple aortic clamping, and OPCAB techniques in
CABG showed significantly better cognitive outcomes in the single aortic clamp and OPCAB
groups. The results discount cardiopulmonary bypass as the primary cause of brain injury after
CABG and support the use of reduced aortic manipulation strategies.
122 Endothelial injury and acquired aspirin resistance as promoters of regional
thrombin formation and early vein graft failure after coronary artery
bypass grafting
Robert S. Poston, MD, Junyan Gu, MD, PhD, James M. Brown, MD, James S. Gammie, MD,
Charles White, MD, Lei Nie, PhD, Richard N. Pierson, III, MD, and Bartley P. Griffith, MD,
Baltimore, Md
Development of aspirin resistance after OPCAB was frequent and associated with an increased
risk of early vein graft thrombosis. This effect was particularly pronounced in the setting of
vein grafts with significant endothelial disruption.
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131 Stent-graft repair for thoracic aortic disease: Results of an independent
nationwide study in France from 1999 to 2001 
Jean-Baptiste Ricco, MD, PhD, Jérome Cau, MD, Christophe Marchand, MD,
Michel Marty, MD, Marie-Hélène Rodde-Dunet, MD, Pierre Fender, MD,
Hubert Allemand, MD, and Andrew Corsini, BA, Poitiers and Paris, France
The purpose of this study was to assess the overall short-term outcome of stent-graft repair for
TAD in France over a 2-year period. A total of 166 stent-graft repairs for aortic disease were
performed, mainly by surgeons (88%). There were 49 complications, including 17 (10%)
postoperative deaths and 27 (16.3%) endoleaks. This nationwide study demonstrates that stent-
graft repair for TAD can be performed with acceptable postoperative morbidity.
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138 An Egr-1 master switch for arteriogenesis: Studies in Egr-1 homozygous
negative and wild-type animals
Cristian Sorin Sarateanu, MD, Mauricio A. Retuerto, BS, James T. Beckmann, BS,
Leslie McGregor, BS, JoAnn Carbray, BS, Gerald Patejunas, PhD, Lina Nayak,
Jeffrey Milbrandt, MD, and Todd K. Rosengart, MD, Evanston and Chicago, Ill, and St Louis,
Mo
C57 BL (knockout) mice deficient in the early growth response 1 (Egr-1) gene having
undergone excision of the femoral artery demonstrated a relative deficiency in arteriogenesis
compared with wild-type littermates. Rats treated with adenoviral vector encoding for egr-1
after vascular excision demonstrated nearly complete recovery of hind-limb perfusion compared
with control-injected animals. These findings suggest that Egr-1 plays a pivotal role in vascular
homeostasis and reperfusion responses after vascular occlusions.
146 Technical challenges in totally endoscopic robotic coronary artery bypass
grafting
J. Bonatti, MD, FETCS, T. Schachner, MD, N. Bonaros, MD, A. O¨ hlinger, MD, M. Danzmayr,
P. Jonetzko, MD, G. Friedrich, MD, C. Kolbitsch, MD, DEAA, P. Mair, MD, and
G. Laufer, MD, Innsbruck, Austria
Consequences of technical difficulties in robotic totally endoscopic coronary artery bypass
grafting were investigated in 40 patients. Technical challenges were encountered in 50% and
translated into markedly increased operative time, moderately prolonged postoperative
ventilation time, and slightly increased hospital stay. Hospital survival and revascularization
results were not compromised.
154 Performance analysis of interactive multimodal CME retraining on attitude
toward and application of OPCAB 
Alexander Albert, MD, Eric A. Peck, MD, Patrick Wouters, MD, PhD,
Jan Van Hemelrijck, MD, PhD, Christophe Bert, MD, PhD, and Paul Sergeant, MD, PhD,
Leuven, Belgium, and Baltimore, Md
A multimodal, interactive and individualized CME has a considerable impact on attitude and
application of a new and complex surgical procedure, conditional of the application of current
knowledge of instructional design. This effect lasts, even in the later clinical confrontation.
Surgery for Congenital
Heart Disease
(CHD)
163 Single-ventricle palliation for high-risk neonates: The emergence of an
alternative hybrid stage I strategy
Emile A. Bacha, MD, Suanne Daves, MD, Joel Hardin, MD, Ra-id Abdulla, MD,
Jennifer Anderson, MD, Madelyn Kahana, MD, Peter Koenig, MD, Bassem N. Mora, MD,
Mehmet Gulecyuz, MD, Joanne P. Starr, MD, Ernerio Alboliras, MD, Satinder Sandhu, MD,
and Ziyad M. Hijazi, MD, Chicago, Ill
Stage I palliation in high-risk neonates carries a high mortality. This pilot study documents
results after hybrid stage I palliation consisting of branch PA banding and ductal stenting via
sternotomy. Hospital survival was 78%, and actual survival to stage II was 61%.
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172 Intermediate outcomes after the Fontan procedure in the current era
Michael E. Mitchell, MD, Richard F. Ittenbach, PhD, J. William Gaynor, MD,
Gil Wernovsky, MD, Susan Nicolson, MD, and Thomas L. Spray, MD, Louisville, Ky, and
Philadelphia, Pa
In a cross-sectional follow-up study of 310 survivors of the Fontan operation between 1992 and
1999, acceptable survival outcomes were observed during intermediate follow-up. Anatomic
diagnosis and stage I reconstruction do not predict poor intermediate-term survival outcomes or
parental assessment of health performance, school performance, or cardiac functional status.
181 The relationship of postoperative electrographic seizures to
neurodevelopmental outcome at 1 year of age after neonatal and infant
cardiac surgery
J. William Gaynor, MD, Gail P. Jarvik, MD, PhD, Judy Bernbaum, MD, Marsha Gerdes, PhD,
Gil Wernovsky, MD, Nancy B. Burnham, RN, MSN, Jo Ann D’Agostino, CRNP,
Elaine Zackai, MD, Donna M. McDonald-McGinn, MS, CGC, Susan C. Nicolson, MD,
Thomas L. Spray, MD, and Robert R. Clancy, MD, Philadelphia, Pa, and Seattle, Wash
The occurrence of a postoperative seizure is a marker of central nervous system injury.
However, in this study, the occurrence of a seizure after infant cardiac surgery was not
predictive of a worse neurodevelopmental outcome at 1 year of age.
190 Brain magnetic resonance imaging abnormalities after the Norwood
procedure using regional cerebral perfusion
Catherine L. Dent, MD, James P. Spaeth, MD, Blaise V. Jones, MD, Steven M. Schwartz, MD,
Tracy A. Glauser, MD, Barbara Hallinan, MD, Jeffrey M. Pearl, MD, Philip R. Khoury, MS,
and C. Dean Kurth, MD, Cincinnati, Ohio
Regional cerebral perfusion has been adopted during the Norwood procedure to avoid circulatory
arrest–associated brain ischemia. To assess its impact on neurologic injury, brain imaging was
performed on infants before and after the Norwood operation. Despite adoption of this technique,
brain ischemia remains common, occurring in the majority of infants after surgery.
Cardiothoracic
Transplantation
(TX)
198 Bronchial airway anastomotic complications after pediatric lung
transplantation: Incidence, cause, management, and outcome
Cliff K. Choong, FRACS, Stuart C. Sweet, MD, Jennifer Bell Zoole, BSN,
Tracey J. Guthrie, BSN, Eric N. Mendeloff, MD, Fabio J. Haddad, MD, Pam Schuler, MD,
Maite De La Morena, MD, and Charles B. Huddleston, MD, St Louis, Mo
Airway complications are a significant cause of morbidity after pediatric lung transplantations.
The majority are successfully treated, and patient outcomes are not adversely affected.
204 Role of open lung biopsy in lung transplant recipients in a single children’s
hospital: A 13-year experience
Cliff K. Choong, FRACS, Fabio J. Haddad, MD, Charles B. Huddleston, MD,
Jennifer Bell, RN, Tracey J. Guthrie, BSN, Eric N. Mendeloff, MD, Pam Schuler, MD,
Maite De La Morena, MD, and Stuart C. Sweet, MD, St Louis, Mo
Open lung biopsy can be performed safely, and established or confirmed a diagnosis in 97% of
the cases in this study. A change in therapy occurred in 69% of the cases as a result of the
diagnosis made from open lung diagnosis. Open lung biopsy appears to be a useful tool.
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209 Chronic aspiration of gastric fluid accelerates pulmonary allograft
dysfunction in a rat model of lung transplantation
Matthew G. Hartwig, MD, James Z. Appel, MD, Bin Li, MD, PhD, Chong-Chao Hsieh, MD,
Yong Han Yoon, MD, Shu S. Lin, MD, PhD, William Irish, PhD, William Parker, PhD, and
R. Duane Davis, MD, Durham and Research Triangle Park, NC
Chronic aspiration accelerates pulmonary allograft failure and may promote mononuclear cell
graft infiltration and a profibrotic cytokine milieu.
218 Modified reperfusion in clinical lung transplantation: The results of 100
consecutive cases
Gabriel T. Schnickel, MD, David J. Ross, MD, Ramin Beygui, MD, Ali Shefizadeh, BS,
Hillel Laks, MD, Rajan Saggar, MD, Joseph P. Lynch III, MD, and Abbas Ardehali, MD, Los
Angeles, Calif
Altering the content and conditions of the initial reperfusate in human lung transplantation is
associated with a low incidence of severe pulmonary graft dysfunction and favorable short-term
outcomes.
Brief Communications 224 Leiomyosarcoma of the left atrium mimicking a left atrial myxoma
Alessandro Mazzola, MD, Jean-Philippe Spano, MD, PhD, Marialuisa Valente, MD,
Renato Gregorini, MD, Carmine Villani, MD, Mauro Di Eusanio, MD, Marco Ciocca, MD,
Ugo Minuti, MD, Raffaele Giancola, MD, Cristina Basso, MD, PhD, and
Gaetano Thiene, MD, FRCP, Teramo and Padua, Italy, and Paris, France
226 Ventricular lateral wall rupture after myocardial infarction detected by
means of multislice computed tomography
Stefan Klotz, MD, Eva M. Fallenberg, MD, Andreas Hoffmeier, MD, Tonny D. T. Tjan, MD,
and Hans H. Scheld, MD, Muenster, Germany
228 Incorporating a pediatric concept into tricuspid valve endocarditis: One and
a half ventricle repair
Shu-Chien Huang, MD, Nai-Hsin Chi, MD, I-Hui Wu, MD, Hsi-Yu Yu, MD, En-Ting Wu, MD,
Shoei-Shen Wang, MD, Fang-Yue Lin, MD, and Yih-Sharng Chen, MD, Taipei, Taiwan,
Republic of China
230 Aortocoronary dissection complicating angioplasty of chronically occluded
right coronary arteries: Is a conservative approach the right approach?
Ian Hunt, MRCS, Matthew E. Faircloth, MRCP, Pranava Sinha, MCh,
Michael S. Marber, PhD, FRCP, Graham E. Venn, MS, FRCS, and
Christopher P. Young, MS, FRCS, London, United Kingdom
232 A localized intimomedial defect resulted in aortic regurgitation
Naoto Morimoto, MD, Yutaka Okita, MD, Kenji Okada, MD, Teruo Yamashita, MD,
Keitaro Nakagiri, MD, Ayako Maruo, MD, Yujiro Kawanishi, MD, Masamichi Matsumori, MD,
and Mitsuru Asano, MD, Kobe, Japan
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233 Novel left ventriculoplasty for nonischemic dilated cardiomyopathy with
functional mitral regurgitation
Hiroshi Irie, MD, PhD, Tadashi Isomura, MD, PhD, Fumikazu Nomura, MD, PhD,
Taiko Horii, MD, PhD, Joji Hoshino, MD, Haruka Makinae, MD, and
Hisayoshi Suma, Kanagawa, Japan
235 Surgical treatment of an aneurysm involving ascending aorta, aortic arch,
and a rupture of a descending aortic aneurysm 26 years following acute type
A aortic dissection
Christian Ku¨hn, MD, Omke E. Teebken, MD, Ju¨rgen Weidemann, MD, Matthias Karck, MD,
Maximillian Pichlmaier, MD, and Axel Haverich, MD, Hannover, Germany
237 Persistent severe vasospasm in off-pump coronary artery bypass surgery:
The value of intraluminal stenting
Pankaj Saxena, MCh, DNB, Igor E. Konstantinov, MD, PhD, Miriam Koniuszko, MBBS,
Tushar Singh, MBBS, and Mark A. J. Newman, FRACS, Perth, Australia
239 Management of new-onset mitral regurgitation with intraoperative
angiography and intraoperative percutaneous coronary intervention
James P. Greelish, MD, Susan S. Eagle, MD, David X. Zhao, MD, Robert J. Deegan, MD,
Marshall H. Crenshaw, MD, Jorge M. Balaguer, MD, Rashid M. Ahmad, MD, and
John G. Byrne, MD, Nashville, Tenn
240 Aortobronchial fistula after aortic coartactation
Alfonso L. Quintana, MD, PhD, Esther Martínez Aguilar, MD,
Alvaro Fernandez Heredero, MD, Vicente Riambau, MD, Laura Paul, MD, and
Francisco Acín, MD, PhD, Madrid, Spain
243 Monobloc aorto-mitral homograft or mechanical valve replacement: A new
surgical option for extensive bivalvular endocarditis
J. F. Obadia, MD, PhD, R. Hénaine, MD, C. Bergerot, MD, I. Ginon, MD, P. Nataf, MD,
N. Chavanis, MD, J. Robin, MD, PhD, X. André-Fouët, MD, J. Ninet, MD, and
O. Raisky, MD, PhD, Lyon and Saint Denis, France
245 Origin of left subclavian artery from ascending aorta: A variant of double
aortic arch
K. Mahadevan Krishnamoorthy, DM, DNB, Hemant Madan, MD, and
Jaganmohan A. Tharakan, DM, Trivandrum, India
247 Intermediate outcomes of fenestrated Fontan procedures
S. Garekar, MD, H. L. Walters, III, MD, R. E. Delius, MD, R. L. Thomas, PhD, and
R. D. Ross, MD, Detroit, Mich
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